Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Salvarani

Showing results (121-130 of 625) with videos related to

Pageof 63
Sort By:
Annals of the Rheumatic Diseases|July 8, 2020
Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu <i>et al</i>Carlo Salvarani, Gianluigi Bajocchi, Pamela Mancuso, et al.
Clinical and Experimental Rheumatology|September 12, 2013
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximabAlberto Lo Gullo, Gianluigi Bajocchi, Giulia Cassone, et al.
Clinical Rheumatology|January 6, 2018
Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppressionAlessandra Soriano, Nazareno Smerieri, Stefano Bonilauri, et al.
Expert Review of Clinical Immunology|December 5, 2022
Rare forms of inflammatory myopathies - part I, generalized formsClaudio Galluzzo, Ilaria Chiapparoli, Ada Corrado, et al.
Expert Review of Clinical Immunology|December 5, 2022
Rare forms of inflammatory myopathies - part II, localized formsClaudio Galluzzo, Ilaria Chiapparoli, Ada Corrado, et al.
Frontiers in Medicine|March 13, 2023
Updates on the diagnosis and monitoring of giant cell arteritisSara Monti, Valentin Sebastian Schäfer, Francesco Muratore, et al.
Neurology|March 7, 2014
Treatment of primary CNS vasculitis with rituximab: case reportCarlo Salvarani, Robert D Brown, John Huston, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Imaging findings in primary central nervous system vasculitisGiulio Zuccoli, Nicolo Pipitone, Anshul Haldipur, et al.
Drugs in Context|January 28, 2021
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung diseaseCaterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.
Clinical and Experimental Rheumatology|May 24, 2014
Catastrophic primary central nervous system vasculitisCarlo Salvarani, Robert D Brown, Jonathan M Morris, et al.
Pageof 63

Showing results (121-130 of 625) with videos related to

Sort By:
Pageof 63
Annals of the Rheumatic Diseases|July 8, 2020
Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu <i>et al</i>Carlo Salvarani, Gianluigi Bajocchi, Pamela Mancuso, et al.
Clinical and Experimental Rheumatology|September 12, 2013
Granulomatosis with polyangiitis presenting as a renal mass successfully treated with rituximabAlberto Lo Gullo, Gianluigi Bajocchi, Giulia Cassone, et al.
Clinical Rheumatology|January 6, 2018
Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppressionAlessandra Soriano, Nazareno Smerieri, Stefano Bonilauri, et al.
Expert Review of Clinical Immunology|December 5, 2022
Rare forms of inflammatory myopathies - part I, generalized formsClaudio Galluzzo, Ilaria Chiapparoli, Ada Corrado, et al.
Expert Review of Clinical Immunology|December 5, 2022
Rare forms of inflammatory myopathies - part II, localized formsClaudio Galluzzo, Ilaria Chiapparoli, Ada Corrado, et al.
Frontiers in Medicine|March 13, 2023
Updates on the diagnosis and monitoring of giant cell arteritisSara Monti, Valentin Sebastian Schäfer, Francesco Muratore, et al.
Neurology|March 7, 2014
Treatment of primary CNS vasculitis with rituximab: case reportCarlo Salvarani, Robert D Brown, John Huston, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Imaging findings in primary central nervous system vasculitisGiulio Zuccoli, Nicolo Pipitone, Anshul Haldipur, et al.
Drugs in Context|January 28, 2021
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung diseaseCaterina Vacchi, Andreina Manfredi, Giulia Cassone, et al.
Clinical and Experimental Rheumatology|May 24, 2014
Catastrophic primary central nervous system vasculitisCarlo Salvarani, Robert D Brown, Jonathan M Morris, et al.
Pageof 63